Evidence map›Paper›PMID 27449271›Full record

Trial reportDrug and alcohol dependence2016

Use of multiple tobacco products in a national sample of persons enrolled in addiction treatment.

Joseph Guydish, Barbara Tajima, Sowmya Pramod, Thao Le, Noah R Gubner, Barbara Campbell, Paul Roman

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. A Comparison of Daily Versus Weekly Electronic Cigarette Users in Treatment for Substance Abuse.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2018
    Article
  18. Article
  19. Article
  20. Drug abuse staff and clients smoking together: A shared addiction.Journal of substance abuse treatment · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Joseph GuydishPhilip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States. Electronic address: joseph.guydish@ucsf.edu.
Barbara TajimaPhilip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States.
Sowmya PramodPhilip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States.
Thao LePhilip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States.
Noah R GubnerPhilip R. Lee Institute for Health Policy Studies, University of California San Francisco, 3333 California St., Ste. 265, San Francisco, CA 94118, United States.
Barbara CampbellDepartment of Public Health and Preventive Medicine, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, United States.
Paul RomanCenter for Research on Behavioral Health and Human Service Delivery, Owens Institute for Behavioral Research, 106 Barrow Hall, University of Georgia, Athens, GA 30602, United States.
Lee University · USUniversity of California, San Francisco · USOregon Health & Science University · USUniversity of Georgia · US

Funding

TREATMENTS FOR COMPLEX PATIENTS IN NEW SETTINGSP50DA009253 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DELUCCHI, KEVIN L. · 1994 to 2014
$28.2M
Marketing, FDA communication, tobacco perceptions and use in addiction treatmentR01DA036066 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GUYDISH, JOSEPH R · 2013 to 2016
$3.0M
NIDA NIH HHS P50 DA009253NIDA NIH HHS R01 DA036066
6 · The paper itself

Abstract

objectiveTo explore use of tobacco products in relationship to marketing exposure among persons in addiction treatment.

methodA random sample of treatment programs was drawn from the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN). Participants in each program completed surveys concerning use of tobacco products (N=1113). Exposure to tobacco marketing and counter-marketing, advertising receptivity, and perceived health risks of smoking were tested for their association with use of multiple tobacco products.

resultsPrevalence of combustible cigarette use was 77.9%. Weekly or greater use of other products was: e-cigarettes (17.7%), little filtered cigars (8.6%), smokeless tobacco (5.2%), and standard cigars (4.6%) with 24.4% using multiple tobacco products. Compared to single product users, multiple product users smoked more cigarettes per day (OR=1.03, 95% CI 1.01-1.05, p<0.001), were more likely to have tried to quit (OR=1.41, 95% CI 1.02-1.96, p=0.041), reported greater daily exposure to advertising for products other than combustible cigarettes (OR=1.93, CI 1.35-2.75, p<0.001), and greater daily exposure to tobacco counter-marketing (OR=1.70, 95% CI: 1.09-2.63, p=0.019).

conclusionHeavier smokers and those trying to quit may be more likely to use e-cigarettes, little filtered cigars, or smokeless tobacco and have greater susceptibility to their advertising. This highlights the importance of regulating advertising related to smoking cessation as their effectiveness for this purpose has not been demonstrated.

Indexed as

Substance Abuse Treatment CentersAdultBehavior, AddictiveElectronic Nicotine Delivery SystemsFemaleHumansMaleMarketingMiddle AgedNational Institute on Drug Abuse (U.S.)SmokingSmoking CessationSmoking PreventionSubstance-Related DisordersSurveys and QuestionnairesTobacco ProductsDrug treatmentNicotinePolicyTobacco

Identifiers

PMID27449271
PMCPMC4983463
OpenAlexW2466016203

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.